275
Participants
Start Date
September 18, 2019
Primary Completion Date
February 27, 2030
Study Completion Date
February 27, 2030
Tulmimetostat
Tulmimetostat dosed once per day orally in 28 day cycles
Enzalutamide
Enzalutamide dosed once per day orally in 28 day cycles
RECRUITING
NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center, New York
WITHDRAWN
Weill Medical College of Cornell University, New York
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
University Hospital Complex of Santiago (CHUS), Santiago de Compostela
RECRUITING
University Hospital of Girona Dr. Josep Trueta, Girona
RECRUITING
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RECRUITING
Gruppo Humanitas - Humanitas Research Hospital - Cancer Center, Rozzano
RECRUITING
National Cancer Institute, IRCCS, Milan
RECRUITING
European Institute of Oncology (IEO), IRCCS, Milan
WITHDRAWN
University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore
RECRUITING
Gachon University Gil Medical Center, Incheon
RECRUITING
University of Virginia Health System, Charlottesville
RECRUITING
University Clinic of Navarra - Madrid, Madrid
RECRUITING
University Hospital 12 de Octubre, Madrid
RECRUITING
University Hospital Quiron Madrid, Madrid
RECRUITING
University Clinic of Navarra - Pamplona, Pamplona
RECRUITING
Bergonie Institute, Bordeaux
RECRUITING
University Clinical Hospital of Salamanca, Salamanca
RECRUITING
Irccs University Hospital of Bologna, Bologna
RECRUITING
University Hospital Virgen del Rocio (HUVR), Seville
RECRUITING
Keimyung University - Dongsan Medical Center, Daegu
RECRUITING
Nantes University Hospital Center - Hotel Dieu Hospital (Satellite), Nantes
RECRUITING
Nantes University Hospital Center - Hotel Dieu Hospital, Nantes
RECRUITING
Nord Laennec Hospital, Saint-Herblain
WITHDRAWN
University of Cincinnati Medical Center, Cincinnati
RECRUITING
Valencia Oncology Institute (IVO), Valencia
WITHDRAWN
University of Michigan Hospital, Ann Arbor
RECRUITING
South Texas Accelerated Research Therapeutics (Start) - Midwest Location, Grand Rapids
RECRUITING
Oscar Lambret Center, Lille
RECRUITING
University of Chicago Medical Center, Chicago
RECRUITING
Strasbourg Europe Institut of Cancerology, Strasbourg
RECRUITING
Leon Berard Center, Lyon
RECRUITING
South Texas Accelerated Research Therapeutics, San Antonio
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Swedish Cancer Institute, Seattle
RECRUITING
Winship Cancer Institute of Emory University, Atlanta
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Hackensack University Medical Center, Hackensack
WITHDRAWN
Montefiore Einstein Center for Cancer Care, The Bronx
RECRUITING
Fred Hutchinson Cancer, Seattle
RECRUITING
"University Polyclinic Foundation Agostino Gemelli - IRCCS", Rome
RECRUITING
University Teaching Centre, Early Clinical Trials Unit, Gdansk
RECRUITING
Polish Mother's Memorial Hospital-Research Institute, Lodz
RECRUITING
University Teaching Hospital in Poznan, Department of Gynecologic Oncology, Poznan
RECRUITING
Medical Center Pratia Poznan, Skorzewo
RECRUITING
Maria Sklodowska-Curie - National Research Institute of Oncology, Warsaw
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Gangnam Severance Hospital, Seoul
RECRUITING
University Hospital Vall d'Hebron, Barcelona
RECRUITING
University Hospital Son Espases, Palma de Mallorca
RECRUITING
Royal United Hospital, Bath
RECRUITING
University Hospitals of Leicester NHS Trust, Leicester
RECRUITING
Royal Marsden Hospital - London, London
RECRUITING
Imperial College Healthcare NHS Trust, London
RECRUITING
The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester
RECRUITING
Royal Marsden Hospital - Sutton, Sutton
RECRUITING
Musgrove Park Hospital, Taunton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY